MACS CARDIOVASCULAR SUBSTUDY HIV

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 “多中心艾滋病队列研究”(MACS)是对人类免疫缺陷病毒(HIV)/艾滋病在男性中的自然历史进行的一项大型、长期的研究。近年来，美国的艾滋病毒/艾滋病疫情发生了变化：高效抗逆转录病毒疗法(HAART)减少了艾滋病毒相关并发症，延长了生存时间。然而，一些人会出现HAART的副作用，如身体形态改变，高胆固醇和甘油三酯(血液中的脂肪)，和/或高血糖/糖尿病。目前尚不清楚这些副作用或慢性艾滋病毒感染本身是否会影响心脏病的发生率。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The "Multicenter AIDS Cohort Study" (MACS) is a large, long term study of the natural history of human immunodeficiency virus (HIV)/AIDS in men. In recent years, the HIV/AIDS epidemic in the United States has changed: highly active antiretroviral therapy (HAART) has led to fewer HIV-related complications and longer survival. However, some people develop side effects from HAART such as body shape changes, high cholesterol and triglycerides (fats in the blood), and/or high blood sugar/diabetes mellitus. It is not known if these side effects, or chronic HIV infection itself, will affect rates of heart disease.